Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Statistics

Total Valuation

KNSA has a market cap or net worth of $1.53 billion. The enterprise value is $1.32 billion.

Market Cap	1.53B
Enterprise Value	1.32B

Important Dates

The last earnings date was Tuesday, October 29, 2024, before market open.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	n/a

Share Statistics

KNSA has 72.20 million shares outstanding. The number of shares has increased by 1.53% in one year.

Current Share Class	41.57M
Shares Outstanding	72.20M
Shares Change (YoY)	+1.53%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	4.90%
Owned by Institutions (%)	50.56%
Float	16.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	46.03
PS Ratio	3.92
Forward PS	3.00
PB Ratio	3.50
P/TBV Ratio	3.64
P/FCF Ratio	137.91
P/OCF Ratio	136.20
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	118.71

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.02.

Current Ratio	3.24
Quick Ratio	2.59
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	0.95
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -2.15% and return on invested capital (ROIC) is -3.79%.

Return on Equity (ROE)	-2.15%
Return on Assets (ROA)	-3.16%
Return on Capital (ROIC)	-3.79%
Revenue Per Employee	$1.29M
Profits Per Employee	-$30,532
Employee Count	297
Asset Turnover	0.74
Inventory Turnover	5.52

Taxes

Income Tax	-7.66M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.01% in the last 52 weeks. The beta is 0.35, so KNSA's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+35.01%
50-Day Moving Average	24.44
200-Day Moving Average	21.81
Relative Strength Index (RSI)	34.97
Average Volume (20 Days)	365,673

Short Selling Information

The latest short interest is 4.21 million, so 5.84% of the outstanding shares have been sold short.

Short Interest	4.21M
Short Previous Month	4.01M
Short % of Shares Out	5.84%
Short % of Float	25.01%
Short Ratio (days to cover)	13.50

Income Statement

In the last 12 months, KNSA had revenue of $384.10 million and -$9.07 million in losses. Loss per share was -$0.13.

Revenue	384.10M
Gross Profit	234.44M
Operating Income	-26.24M
Pretax Income	-18.02M
Net Income	-9.07M
EBITDA	-24.40M
EBIT	-26.24M
Loss Per Share	-$0.13

Balance Sheet

The company has $223.78 million in cash and $10.60 million in debt, giving a net cash position of $213.19 million or $2.95 per share.

Cash & Cash Equivalents	223.78M
Total Debt	10.60M
Net Cash	213.19M
Net Cash Per Share	$2.95
Equity (Book Value)	437.01M
Book Value Per Share	6.06
Working Capital	215.35M

Cash Flow

In the last 12 months, operating cash flow was $11.24 million and capital expenditures -$140,000, giving a free cash flow of $11.10 million.

Operating Cash Flow	11.24M
Capital Expenditures	-140,000
Free Cash Flow	11.10M
FCF Per Share	$0.15

Margins

Gross margin is 61.04%, with operating and profit margins of -6.83% and -2.36%.

Gross Margin	61.04%
Operating Margin	-6.83%
Pretax Margin	-4.35%
Profit Margin	-2.36%
EBITDA Margin	-6.35%
EBIT Margin	-6.83%
FCF Margin	8.95%

Dividends & Yields

KNSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.53%
Shareholder Yield	-1.53%
Earnings Yield	-0.59%
FCF Yield	0.73%

Analyst Forecast

The average price target for KNSA is $36.60, which is 72.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$36.60
Price Target Difference	72.56%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	22.67%
EPS Growth Forecast (5Y)	34.72%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KNSA has an Altman Z-Score of 6.81 and a Piotroski F-Score of 3.

Altman Z-Score	6.81
Piotroski F-Score	3